ga naar hoofdinhoud
Informatie voor zorgverleners Behandelprotocollen Immuun gemedieerde trombocytopenie (ITP) Richtlijnen en literatuur

Richtlijnen

Klik HIER voor de richtlijn 'Immuun trombocytopenie' van de NVvH werkgroep Benigne hematologie.

Klik HIER voor de addendum richtlijn 'Immuun trombocytopenie' van de NVvH werkgroep Benigne hematologie.

Literatuur 

  1. Peng J. et al. Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study. J Thromb Haemost. 2014 Apr; 12 (4):497-504
  2. Chugh S. et al. Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis. Lancet Haematol 2015 Feb;2 (2) e75-81
  3. Goodier et al. Neuraxial anesthesia in patients with thrombocytopenia: a multisite retrospective cohort study. Anesth Analg. 2015;121 (4) :988-991
  4. Ghanima W. Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2015 Apr 25;385 (9978):1653-61
  5. Matschke J. et al. A randomized trial of daily prednisone versus pulsed dexamethasone in treatment-naïve adult patients with immune thrombocytopenia: EIS 2002 study. Acta Haematol 2016;136 (2):101-7
  6. Wei Y. et al. High-dose dexamethasone vs prednisone for treatment of adult immune trombocytopenia: a prospective multicenter randomized trial
  7. Mithoowani S. et al. High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis. Lancet Haematol 2016 Oct; 3 (10):e489-e496
  8. Cuker A et al. How I treat refractory immune thrombocytopenia. Blood 2016 Sep 22; 128 (12):1547-54
  9. Douglas B. et al. Thrombocytopenia in pregnancy. Blood 2017 130:2271-2277
  10. Porcelijn L. et al. Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients. Blood 2017 Jun 22;129 (25):3389-3391
  11. Feng R. et al. GPIIb/IIIa autoantibody predicts better rituximab response in ITP. Br J Haematol. 2018 jul; 182 (2):305-307
  12. Arnold DM et al. The effect of rituximab on anti-platelet autoantibody levels in patients with immune trombocytopenia. Br J Haematol. 2017 jul;178 (2):302-307
  13. Tastaldi L. et al. Laparoscopic splenectomy for immune thrombocytopenia (ITP): long-term outcomes of a modern cohort. Surg Endosc. 2018 jul 9
  14. Chaturvedi S. et al. Splenectomy for immune thrombocytopenia: down but not out. Blood. 2018 Mar 15; 131 (11):1172-1182
  15. Cantoni S. et al. Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: a retrospective collaborative survey from Italian hematology centers. Am J Hematol 2018 Jan; 93 (1):58-64
  16. Sun T. et al. Daratumumab in relapsed or refractory pediatric immune trombocytopenia. N Engl J Med 2025 May 29; 392 (20):2069-2071
  17. Strüßmann T. et al. Long-term complete remissions of refractory severe idiopathic immune thrombocytopenia treated with daratumumab: a case series. Br J Haematol. 2024 Oct; 205 (4):1618-1621

 

Ga terug naar de ITP homepage of lees meer over ITP:

Ga terug naar de algemene homepage Behandelprotocollen.